{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:26:29Z","timestamp":1790245589865,"version":"4.1.0"},"reference-count":44,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T00:00:00Z","timestamp":1575417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Shire International GmbH, Zug, Switzerland, a member of the Takeda group of companies"}],"content-domain":{"domain":["aspenjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Parenter Enteral Nutr"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chronic intestinal failure (CIF) due to short\u2010bowel syndrome (SBS) is characterized by failure to achieve optimal intestinal adaptation required to maintain oral\/enteral autonomy. The conventional management strategy relies heavily on home parenteral support (PS; parenteral nutrition and\/or intravenous fluids). Teduglutide, an analog of the hormone glucagon\u2010like peptide\u20102, facilitates intestinal adaptation, as evidenced by reductions in PS volume in patients with SBS\u2010associated CIF. In 2016, the European Society for Clinical Nutrition and Metabolism (ESPEN) developed guidelines for the management of adult patients with CIF, consisting of a comprehensive list of recommendations. Owing to the limited number of studies at the time of the finalization of the GRADE\u2010method review of the available literature, teduglutide received a moderate grade of evidence (GOE) as the first choice for growth\u2010factor treatment in patients with SBS\u2010CIF. The GOE was also low for 7 points of recommended information to be discussed with the candidate patients. This review summarizes findings from recent studies that fill some gaps identified in the 2016 ESPEN guidelines regarding the use of teduglutide in the management of SBS\u2010CIF. Collectively, these studies provide useful information about the probability and timing of clinical response in the individual patient. Also, recent studies report longer\u2010term safety findings with teduglutide. These results can help physicians better manage patients with SBS\u2010CIF by aligning clinical decision making with specific disease characteristics, setting the right expectations, and encouraging treatment adherence.<\/jats:p>","DOI":"10.1002\/jpen.1757","type":"journal-article","created":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T23:11:59Z","timestamp":1575501119000},"page":"968-978","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Translation of Evidence Into Practice With Teduglutide in the Management of Adults With Intestinal Failure due to Short\u2010Bowel Syndrome: A Review of Recent Literature"],"prefix":"10.1002","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1773-8330","authenticated-orcid":false,"given":"Loris","family":"Pironi","sequence":"first","affiliation":[{"name":"Center for Chronic Intestinal Failure St. Orsola Hospital University of Bologna  Bologna Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,12,4]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2014.08.017"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2016.01.020"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2018.07.036"},{"key":"e_1_2_6_5_1","volume-title":"Surgical Treatment: Evidence\u2010Based and Problem\u2010Oriented","author":"Robinson MK","year":"2001"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00710.x"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)70064-X"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.091108"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2016.02.011"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2012.08.007"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70388-4"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.sempedsurg.2009.11.010"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.50.3.428"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.15.7911"},{"issue":"1","key":"e_1_2_6_15_1","first-page":"E77","article-title":"Intestinal growth\u2010promoting properties of glucagon\u2010like peptide\u20102 in mice","volume":"273","author":"Tsai CH","year":"1997","journal-title":"Am J Physiol"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/00365529850171486"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.7.5840"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/00365520802538195"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.061440"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1177\/1756284818793343"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.218271"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.09.007"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/ctg.2015.69"},{"key":"e_1_2_6_24_1","volume-title":"Full Prescribing Information","author":"GATTEX (teduglutide)","year":"2019"},{"key":"e_1_2_6_25_1","volume-title":"Full Prescribing Information","author":"Revestive (teduglutide)","year":"2019"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.12.029"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.11.023"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S166081"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/jpen.1687"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/ncp.10092"},{"key":"e_1_2_6_31_1","first-page":"616054","article-title":"Short bowel patients treated for two years with glucagon\u2010like peptide 2: effects on intestinal morphology and absorption, renal function, bone and body composition, and muscle function","volume":"2009","author":"Jeppesen PB","year":"2009","journal-title":"Gastroenterol Res Pract"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1177\/0148607111414431"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1177\/0148607112472906"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05812.x"},{"key":"e_1_2_6_35_1","article-title":"Colon polyps in patients with short bowel syndrome before and after teduglutide: post hoc analysis of the STEPS study series [published online August 23, 2019]","author":"Armstrong D","journal-title":"Clin Nutr"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/jpen.1588"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2018.07.024"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2018.06.964"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1177\/0148607114536926"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1177\/0148607115582063"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1177\/0148607113512678"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.09.065"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000212679.14172.33"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1177\/0148607113518946"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.09.064"}],"container-title":["Journal of Parenteral and Enteral Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjpen.1757","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jpen.1757","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jpen.1757","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/aspenjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jpen.1757","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T09:02:24Z","timestamp":1760864544000},"score":1,"resource":{"primary":{"URL":"https:\/\/aspenjournals.onlinelibrary.wiley.com\/doi\/10.1002\/jpen.1757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,4]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["10.1002\/jpen.1757"],"URL":"https:\/\/doi.org\/10.1002\/jpen.1757","archive":["Portico"],"relation":{},"ISSN":["0148-6071","1941-2444"],"issn-type":[{"value":"0148-6071","type":"print"},{"value":"1941-2444","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,4]]},"assertion":[{"value":"2019-06-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}